India emerging as a key player in the global pharmaceutical supply chain
News: India's Contract Research, Development, and Manufacturing Organization (CRDMO) industry is set to double from USD 7 billion to USD 14 billion by 2028, growing at a 14% CAGR, according to a Macquarie Equity Research report. Regulatory support, rising pharmaceutical outsourcing, and global…
Read More